Abstract:Background: Elucidation of the mechanism of ubiquitation has led to novel ways to treat glioblastoma (GBM). A tripartite motif (TRIM) protein mediates a reversible, stringent ubiquitation which is closely related to glioma malignancy. This study intends to screen the most vital and abnormal regulating component of the tripartite motif protein and to explore its underlying mechanisms. Methods: TRIM21 is identified as an important oncogene that accelerates the progression of glioma cell through database in a multidimensional way and this is confirmed in human samples and cells. Tandem Mass Tags (TMT) and MS analysis are performed to discover the substrates of TRIM21.The underlying mechanisms are further investigated by CO-IP, luciferase reporter assays and gain and loss of function assays. In vivo treatment with siRNA is applied to evaluate the therapeutic significance of TRIM21. Result: We screened a panel of TRIM proteins and identified TRIM21, a E3 ubiquitin-protein ligase and autoantigen, as well as a prognostic biomarker for GBM. Functionally, high expression of wild-type TRIM21 accelerates tumor progression in vitro and in vivo, whereas TRIM21 mutants, including one with a critical RING-finger deletion, do not. Mechanistically, TRIM21 stimulates K63-linked ubiquitination and subcellular translocation of active β-catenin from the cytoplasm to the nucleus. Moreover, TRIM21 forms a complex with the β-catenin upstream regulator, TIF1γ, in the nucleus and accelerated its degradation by inducing K48-linked ubiquitination at K5 site, consequently increasing further nuclear β-catenin presence. Endogenous TRIM21 levels are found to be inversely correlated with TIF1γ but positively correlated with β-catenin in glioma tissue microarray experiments. Furthermore, direct injection of TRIM21 small interfering RNA (siRNA) into U87 cell-derived tumors (in vivo treatment with siRNA) is proved to inhibit tumor growth in nude mice. Conclusion: This work suggests that TRIM21/TIF1γ/β-catenin axis is involved in the progression of human GBM. TRIM21 is a promising therapeutic and prognostic biomarker for glioma with hyperactive β-catenin.

Ubiquitination of p21 by E3 ligase RNF135 promotes the proliferation of human glioblastoma cells

Recent Insight into the Role of RING-finger E3 Ligases in Glioma

E3 Ubiquitin-Ligase RNF138 May Regulate P53 Protein Expression to Regulate the Self-Renewal and Tumorigenicity of Glioma Stem Cells.

RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma

UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination

The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression

CRISPR screening of E3 ubiquitin ligases reveals Ring Finger Protein 185 as a novel tumor suppressor in glioblastoma repressed by promoter hypermethylation and miR-587

Ubiquitination of p21 by E3 Ligase TRIM21 Promotes the Proliferation of Human Neuroblastoma Cells

Downregulation of RNF138 Inhibits Cellular Proliferation, Migration, Invasion and EMT in Glioma Cells Via Suppression of the Erk Signaling Pathway

UBE2T Promotes Glioblastoma Malignancy Through Ubiquitination‐mediated Degradation of RPL6

UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway

Repression of PCGF1 Decreases the Proliferation of Glioblastoma Cells in Association with Inactivation of C-Myc Signaling Pathway

NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation

E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma

KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300

Small GTPase RHOE/RND3, a New Critical Regulator of NF‐κB Signalling in Glioblastoma Multiforme?

Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-B1 Target SerpinE1 in Aggressive Glioblastoma Tumors

RNF122 promotes glioblastoma growth via the JAK2/STAT3/c-Myc signaling Axis

Neuroglobin Promotes the Proliferation and Suppresses the Apoptosis of Glioma Cells by Activating the PI3K/AKT Pathway.

Ubiquitin Ligase RNF5 Serves an Important Role in the Development of Human Glioma